J. Rubio

发表

Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience.

M. Quintela, U. A. Herranz, F. J. Afonso, 2018, Translational lung cancer research.

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

M. Lázaro, F. Vázquez, G. Alonso, 2009, Cancer Chemotherapy and Pharmacology.

Non-small cell lung cancer, locally advanced

P. Lambin, S. Kozlov, I. Petersen, 2012 .

Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study—Final data of patients who underwent surgical assessment.

N. Viñolas, B. Massuti, M. Provencio, 2019, Journal of Clinical Oncology.

Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group.

M. Quintela, S. V. Estévez, F. J. Afonso, 2018 .

Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer.

D. Corbacho, I. Pérez, J. Rubio, 2022, Clinical breast cancer.

Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment

G. Escames, J. Giralt, R. Mesía, 2021, Clinical and Translational Oncology.

Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer

R. Salazar, L. Capdevila, M. Llobera, 2019, Clinical and Translational Oncology.

Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy.

D. Corbacho, M. Quintela, A. Herrero, 2019, Journal of Clinical Oncology.